摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

恩氟烷 | 13838-16-9

中文名称
恩氟烷
中文别名
氟醚麻醉剂;五氟氯甲乙醚;2-氯-1,1,2-三氟乙基二氟甲基醚;安氟醚;易使宁
英文名称
enflurane
英文别名
2-chloro-1,1,2,-trifluoroethyl difluoromethyl ether;1,1,2-trifluoro-2-chloroethyl difluoromethyl ether;2-chloro-1-(difluoromethoxy)-1,1,2-trifluoroethane
恩氟烷化学式
CAS
13838-16-9
化学式
C3H2ClF5O
mdl
MFCD00069095
分子量
184.493
InChiKey
JPGQOUSTVILISH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    56 °C
  • 密度:
    1.517
  • 闪点:
    56-57°C
  • 溶解度:
    氯仿(可溶)、DMSO(少量溶解)、二氯甲烷(少量溶解)、甲醇(S
  • 暴露限值:
    TLV-TWA 570 mg/m3 (75 ppm) (ACGIH).
  • 物理描述:
    Enflurane (Ethrane, 2-chloro-1,1,2-trifluoroethyldifluoromethyl ether) is a nonflammable halogenated hydrocarbon that exists as a clear, colorless, odorless to sweet, volatile liquid at ordinary temperature and pressure. Bp: 56.8°C. Density 1.50 g cm-3 at room temperature. Used as an anesthetic.
  • 颜色/状态:
    Clear, colorless liquid
  • 气味:
    Mild, sweet odor
  • 熔点:
    48.5
  • 蒸汽密度:
    Relative vapor density (air = 1): 1.9
  • 蒸汽压力:
    174.5 mm Hg at 20 °C
  • 大气OH速率常数:
    1.19e-14 cm3/molecule*sec
  • 分解:
    Hazardous decomposition products formed under fire conditions. - Carbon oxides, hydrogen chloride gas, hydrogen fluoride.
  • 保留指数:
    486;478;462;478;462
  • 稳定性/保质期:
    在常温常压下保持稳定,应避免与氧化物接触。

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    10
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    6

ADMET

代谢
恩氟烷通过肝脏中的CYP2E1酶代谢,产生无机氟离子,这是恩氟烷代谢的主要代谢物。一份参考资料表明,恩氟烷在肝脏的氧化代谢后只有2-5%被消除,然而更近期的证据表明,大约有9%通过肝脏氧化作用被消除。
Enflurane is metabolized by the CYP2E1 enzyme in the liver to produce inorganic fluoride ions, the major metabolite of enflurane metabolism. One reference indicates that enflurane is only 2-5% eliminated after oxidative metabolism in the liver, however more recent evidence suggests that about 9% is eliminated via hepatic oxidation.
来源:DrugBank
代谢
氟代烷基卤素麻醉剂如氟烷、恩氟烷和异氟烷的毒性与其通过肝细胞色素P450的代谢密切相关。尽管已经证明个别麻醉剂对映体在麻醉效果上存在差异,但关于麻醉剂对映体代谢的报道尚未见诸文献。人肝脏中恩氟烷代谢为二氟甲氧基二氟乙酸(DFMDFA)和无机氟化物,这一过程在体内和体外均由细胞色素P450 2E1催化。本研究的目的是表征恩氟烷外消旋混合物和对映体的代谢,以检验氟代醚类麻醉剂通过细胞色素P450 2E1代谢是否表现出底物立体选择性。在饱和恩氟烷浓度下,测量了来自三个人类肝脏的微体和含有cDNA表达的人类P450 2E1的微体的恩氟烷代谢。通过气相色谱-质谱法检测乙醇酰胺衍生物来定量DFMDFA。在所有三个肝脏的微体中,(R)-恩氟烷的代谢显著高于(S)-恩氟烷,而外消旋恩氟烷的代谢速率通常介于R-和S-对映体之间。研究的三个肝脏中(R)-恩氟烷与(S)-恩氟烷的代谢比率为2.1:1、1.9:1和1.4:1。(R)-、(S)-和外消旋恩氟烷均被表达的P450 2E1代谢。(R)-恩氟烷与(S)-恩氟烷的代谢比率为1.9:1。人类肝脏P450 2E1对(R)-恩氟烷的代谢对映选择性表明,P450 2E1对恩氟烷的代谢是通过直接的底物氧化,而不是通过产生P450依赖的活性氧物种间接进行,这一发现支持了P450 2E1活性位点具有一定限制性并且能够进行立体化学区分的假设。
The toxicity of the chiral fluorinated volatile anesthetics halothane, enflurane, and isoflurane is closely related to their metabolism by hepatic cytochrome P450. Although individual anesthetic enantiomers have been shown to exhibit a difference in anesthetic efficacy, metabolism of anesthetic enantiomers has not been reported. Human liver enflurane metabolism to difluoromethoxydifluoroacetic acid (DFMDFA) and inorganic fluoride is catalyzed in vivo and in vitro by cytochrome P450 2E1. The purpose of this investigation was to characterize enflurane racemate and enantiomer metabolism to test the hypothesis that fluorinated ether anesthetic metabolism by cytochrome P450 2E1 exhibits substrate stereoselectivity. Enflurane metabolism by microsomes from three human livers and by microsomes containing cDNA-expressed human P450 2E1 was measured at saturating enflurane concentrations. DFMDFA was quantitated with gas chromatography-mass spectrometry by detection of the ethanolamide derivative. In microsomes from all three livers, (R)-enflurane metabolism was significantly greater than that of (S)-enflurane, whereas rates of racemic enflurane metabolism were generally between those seen for the R- and S-enantiomers. The ratio of (R)-enflurane to (S)-enflurane metabolism in the three livers studied was 2.1:1, 1.9:1, and 1.4:1. (R)-, (S)-, and racemic enflurane were all metabolized by expressed P450 2E1. The ratio of (R)-enflurane to (S)-enflurane metabolism was 1.9:1. The metabolic enantiomeric selectivity of human liver P450 2E1 for (R)-enflurane suggests that enflurane metabolism by P450 2E1 occurs by direct substrate oxidation, rather than indirectly through the generation of a P450-dependent reactive oxygen species, and supports the hypothesis that the P450 2E1 active site is somewhat restrictive and capable of stereochemical discrimination.
来源:Hazardous Substances Data Bank (HSDB)
代谢
二氟甲氧基二氟乙酸(CHF2OCF2CO2H)已被识别为在大鼠肝脏微粒体体外和人类尿液中通过气相色谱质谱法检测到的氟烷(CHF2OCF2CHCIF)的代谢物。在大鼠肝脏微粒体中形成这种代谢物依赖于NADPH和O2的存在,并且当反应混合物中存在SKF 525-A或CO/O2(8:2,体积比)时,会受到抑制。当氟烷的CHCIF基团或异氟烷(CHF2OCHCICF3)的CHCI基团的C-H键被替换为C-Cl键时,在大鼠肝脏微粒体中几乎不会产生氟离子。这些结果表明,细胞色素P-450催化CHF2OCF2CHCIF的CHCIF基团的氧化脱卤反应,形成CHF2OCF2CO2H和氯离子以及氟离子。相比之下,CHF2基团似乎不容易受到代谢氧化脱卤的影响...
Difluoromethoxydifluoroacetic acid (CHF2OCF2CO2H) has been identified as a metabolite of enflurane (CHF2OCF2CHCIF) in rat liver microsomes in vitro and in human urine by gas chromatography mass spectrometry. The formation of the metabolite in rat liver microsomes was dependent upon the presence of NADPH and O2, and was inhibited when SKF 525-A or CO/O2 (8:2, v/v) were present in the reaction mixture. When the C-H bonds of the CHCIF group of enflurane or of the CHCI group of isoflurane (CHF2OCHCICF3) were replaced with a C-CI bond, virtually no fluoride ion was produced from either derivative in rat liver microsomes. These results indicate that cytochrome P-450 catalyzes the oxidative dehalogenation of CHF2OCF2CHCIF at its CHCIF group to form CHF2OCF2CO2H and chloride and fluoride ions. In contrast, the CHF2 group does not appear to be appreciably susceptible to metabolic oxidative dehalogenation...
来源:Hazardous Substances Data Bank (HSDB)
代谢
恩氟烷是一种氟化挥发性麻醉剂,主要通过呼出的空气中以原形排出。大约10%吸入的恩氟烷在肝脏通过混合功能氧化酶发生氧化代谢。
Enflurane is a fluorinated volatile anesthetic, mostly eliminated unchanged in exhaled air. About 10% of inhaled enflurane undergoes oxidative metabolism in liver via mixed function oxidase.
来源:Hazardous Substances Data Bank (HSDB)
代谢
氟化醚类麻醉药的肝毒性和肾毒性是由细胞色素P450催化的氧化代谢介导的。在体外,通过人类肝脏微粒体将挥发性麻醉药恩氟烷代谢为无机氟离子的过程主要是由细胞色素P450的CYP2E1同种型催化。
Fluorinated ether anesthetic hepatotoxicity and nephrotoxicity are mediated by cytochrome P450-catalyzed oxidative metabolism. Metabolism of the volatile anesthetic enflurane to inorganic fluoride ion by human liver microsomes in vitro is catalyzed predominantly by the cytochrome P450 isoform CYP2E1.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 毒性总结
恩氟烷通过减少间隙连接通道的开放时间并增加间隙连接通道的关闭时间,从而降低了接头传导性。恩氟烷还通过增加脂质膜的流动性,激活肌浆网中的钙依赖性ATP酶。它似乎还能与ATP合酶的D亚单位和NADH脱氢酶结合。恩氟烷还能结合并激活GABA受体、大电导钙激活钾通道、甘氨酸受体,并拮抗谷氨酸受体。这些作用导致去极化减少,因此组织的兴奋性降低,最终产生麻醉效果。
Enflurane induces a reduction in junctional conductance by decreasing gap junction channel opening times and increasing gap junction channel closing times. Enflurane also activates calcium dependent ATPase in the sarcoplasmic reticulum by increasing the fluidity of the lipid membrane. It also appears to bind the D subunit of ATP synthase and NADH dehydogenase. Enflurane also binds to and angonizes the GABA receptor, the large conductance Ca<sup>2+</sup> activated potassium channel, the glycine receptor, and antagonizes the glutamate receptor receptor. These yield a decreased depolarization and therefore, tissue excitability which results in anesthesia.
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 肝毒性
前瞻性、连续血液检测通常显示在大手术和麻醉后的1到2周内血清转氨酶水平有轻微的暂时性升高。然而,ALT水平高于正常上限10倍的情况非常罕见,这表明有显著的肝毒性。临床上明显的、由恩氟烷引起的严重肝损伤虽有报道,但非常罕见。这种损伤类似于卤烷的肝毒性,其特点是血清转氨酶水平急性升高(5到50倍)和在手术和麻醉后2到21天出现黄疸。碱性磷酸酶和γ-谷氨酰转肽酶水平通常只有轻微升高。肝损伤前通常有1到2天的发热,并可能伴有皮疹和嗜酸性粒细胞增多。急性肝损伤可能是自限性的,在4到8周内解决,但可能是严重的,并伴有急性肝衰竭。一个强烈的危险因素是之前暴露于任何卤化麻醉剂,特别是有卤烷肝炎病史或在使用这些药物麻醉后出现不明原因的发热和皮疹。
Prospective, serial blood testing often demonstrates minor transient elevations in serum aminotransferase levels in the 1 to 2 weeks after major surgery and anesthesia. Appearance of ALT levels above 10 times the upper limit of normal, however, is distinctly unusual and points to significant hepatotoxicity. Clinically apparent, severe hepatic injury from enflurane has been reported but is very rare. The injury resembles halothane hepatotoxicity and is marked by acute elevations in serum aminotransferase levels (5- to 50-fold) and appearance of jaundice 2 to 21 days after surgery and anesthesia. There are usually minimal increases in alkaline phosphatase and gammaglutamyl transpeptidase levels. The liver injury is often preceded by a day or two of fever and may be accompanied by rash and eosinophilia. The acute liver injury may be self-limited and resolve within 4 to 8 weeks, but can be severe and associated with acute liver failure. A strong risk factor is previous exposure to any of the halogenated anesthetics and particularly a history of halothane hepatitis or unexplained fever and rash after anesthesia with one of these agents.
来源:LiverTox
毒理性
  • 致癌性证据
A4:不能分类为人类致癌物。
A4: Not classifiable as a human carcinogen.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 致癌物分类
对人类无致癌性(未列入国际癌症研究机构名录)。
No indication of carcinogenicity to humans (not listed by IARC).
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 在妊娠和哺乳期间的影响
◉ 母乳喂养期间使用概述:没有关于恩氟烷在母乳喂养期间的使用经验发表。由于恩氟烷在母亲体内的血清半衰期短,且该药物预期不会被婴儿吸收,因此不需要等待期或弃奶。只要母亲从全身麻醉中恢复到可以哺乳的程度,就可以恢复母乳喂养。当手术中使用多种麻醉剂组合时,请遵循手术期间使用的最具问题的药物的建议。在一项研究中,与那些被禁止哺乳或非哺乳妇女相比,全身麻醉诱导前哺乳的妇女对七氟烷和丙泊酚的需求量有所减少。其他麻醉剂的需求量可能也会受到类似的影响。 ◉ 对哺乳婴儿的影响:截至修订日期,未找到相关已发表信息。 ◉ 对泌乳和母乳的影响:一项随机研究比较了使用全身麻醉、脊髓麻醉或硬脊膜外麻醉进行剖宫产与正常阴道分娩对血清催乳素和催产素的影响以及开始泌乳的时间。全身麻醉使用丙泊酚2 mg/kg和罗库溴铵0.6 mg/kg进行诱导,随后根据需要使用七氟烷和罗库溴铵0.15 mg/kg。分娩后,所有组别的患者接受了催产素30国际单位溶于1 L盐水的输注,如果她们没有高血压,则给予0.2 mg的甲基麦角新碱。全身麻醉组在分娩后给予芬太尼1至1.5 mcg/kg。全身麻醉组(n = 21)的术后催乳素水平高于其他组,开始泌乳的平均时间(25小时)也长于其他组(10.8至11.8小时)。未用药阴道分娩组产后催产素水平高于全身麻醉和脊髓麻醉组。 一项对土耳其医院接受选择性剖宫产分娩的妇女进行的回顾性研究比较了接受布比卡因脊髓麻醉的妇女(n = 170)与接受丙泊酚诱导、七氟烷维持和分娩后给予芬太尼的全身麻醉的妇女(n = 78)。在产后1小时和24小时,两组之间的母乳喂养率没有差异。然而,在产后6个月,全身麻醉组中仍有67%的妇女在哺乳,而脊髓麻醉组中有81%,这具有统计学意义上的差异。
◉ Summary of Use during Lactation:There is no published experience with enflurane during breastfeeding. Because the serum half-life of enflurane in the mother is short and the drug is not expected to be absorbed by the infant, no waiting period or discarding of milk is required. Breastfeeding can be resumed as soon as the mother has recovered sufficiently from general anesthesia to nurse. When a combination of anesthetic agents is used for a procedure, follow the recommendations for the most problematic medication used during the procedure. In one study, breastfeeding before general anesthesia induction reduced requirements of sevoflurane and propofol compared to those of nursing mothers whose breastfeeding was withheld or nonnursing women. It is possible that requirements for other anesthetic agents would be affected similarly. ◉ Effects in Breastfed Infants:Relevant published information was not found as of the revision date. ◉ Effects on Lactation and Breastmilk:A randomized study compared the effects of cesarean section using general anesthesia, spinal anesthesia, or epidural anesthesia, to normal vaginal delivery on serum prolactin and oxytocin as well as time to initiation of lactation. General anesthesia was performed using propofol 2 mg/kg and rocuronium 0.6 mg/kg for induction, followed by sevoflurane and rocuronium 0.15 mg/kg as needed. After delivery, patients in all groups received an infusion of oxytocin 30 international units in 1 L of saline, and 0.2 mg of methylergonovine if they were not hypertensive. Fentanyl 1 to 1.5 mcg/kg was administered after delivery to the general anesthesia group. Patients in the general anesthesia group (n = 21) had higher post-procedure prolactin levels and a longer mean time to lactation initiation (25 hours) than in the other groups (10.8 to 11.8 hours). Postpartum oxytocin levels in the nonmedicated vaginal delivery group were higher than in the general and spinal anesthesia groups. A retrospective study of women in a Turkish hospital who underwent elective cesarean section deliveries compared women who received bupivacaine spinal anesthesia (n = 170) to women who received general anesthesia (n = 78) with propofol for induction, sevoflurane for maintenance and fentanyl after delivery. No differences in breastfeeding rates were seen between the groups at 1 hour and 24 hours postpartum. However, at 6 months postpartum, 67% of women in the general anesthesia group were still breastfeeding compared to 81% in the spinal anesthesia group, which was a statistically significant difference.
来源:Drugs and Lactation Database (LactMed)
吸收、分配和排泄
  • 吸收
恩氟烷通过肺部迅速吸收进入血液循环。其最小肺泡浓度为1.68%。
Enflurane is rapidly absorbed into the circulation through the lungs. The minimum alveolar concentration is oxygen is 1.68%.
来源:DrugBank
吸收、分配和排泄
  • 消除途径
新陈代谢占恩氟烷消除的5-9%,有时会导致肾毒性。通过皮肤的排泄被认为是微量的。
Metabolism accounts for 5-9% of enflurane elimination, sometimes causing nephrotoxicity. Excretion through the skin is believed to be minimal.
来源:DrugBank
吸收、分配和排泄
  • 分布容积
恩氟烷分布到大脑、血液和皮下脂肪。
Enflurane distributes to the brain, blood, and subcutaneous fat.
来源:DrugBank

安全信息

  • 职业暴露限值:
    Ceiling: 2 ppm (15.1 mg/m3) [60-minute] [*Note: REL for exposure to waste anesthetic gas.]
  • 危险品标志:
    F,T
  • 安全说明:
    S23,S26,S36
  • 危险类别码:
    R36
  • 海关编码:
    2909199090
  • 危险品运输编号:
    UN 3334
  • RTECS号:
    KN6800000
  • WGK Germany:
    3
  • 储存条件:
    常温密闭,阴凉通风干燥

SDS

SDS:122bcd334f1a71f7532a3999af2af8ad
查看

制备方法与用途

易使宁化学性质非常稳定,具有较高的全麻效能和中等强度。由于其血/气分配系数较小,诱导麻醉和苏醒过程均较快。该药物具有一定镇痛作用,并能与非去极化肌松药产生协同效应;停止给药后,肌肉松弛作用迅速消失。

易使宁能够抑制心肌功能并降低外周血管阻力,从而导致血压下降。但它不会增加心肌对儿茶酚胺的敏感性,可以与其他药物联合使用以实现控制性降压。

该药物还具有明显的镇静作用,能减少咳嗽和喉痉挛,并且较少引起恶心和呕吐。此外,易使宁还能降低胃肠道逆蠕动和腺体分泌,同时抑制眼内压力,适用于眼科手术。

在吸入后,约80%的药物以原形从肺部呼出,仅有2%至5%被代谢;主要通过肝脏微粒体酶催化转化为氟化物,并随尿液排出。此外,该药物具有较低的脂肪/气分配系数,易于离开脂肪组织并被降解。

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    全身麻醉剂。1.卤代甲基乙基醚作为麻醉剂。
    摘要:
    DOI:
    10.1021/jm00288a014
  • 作为产物:
    参考文献:
    名称:
    全身麻醉剂。3.氟化甲基乙基醚作为麻醉剂。
    摘要:
    DOI:
    10.1021/jm00276a008
  • 作为试剂:
    描述:
    四氯化碳恩氟烷 、 cytochrome P540还原型辅酶II(NADPH)四钠盐 作用下, 以 various solvent(s) 为溶剂, 反应 0.12h, 生成 氯仿
    参考文献:
    名称:
    Stimulatory effect of anesthetics on dechlorination of carbon tetrachloride in guinea-pig liver microsomes
    摘要:
    Effects of the anesthetics isoflurane, enflurane, halothane and sevoflurane on the dechlorination of carbon tetrachloride to produce chloroform were investigated using guinea pig liver microsomes. Under anaerobic conditions, chloroform is produced from carbon tetrachloride by the microsomes in the presence of NADPH, and chloroform production from 86 mu M carbon tetrachloride was enhanced to 146%, 133%, 123% and 115% by the addition of isoflurane, enflurane, halothane and sevoflurane, respectively. The half-life of oxidized cytochrome P450 which remained during the reduction by the addition of NADPH was shortened to 51%, 54%, 60% and 80% by isoflurane, enflurane, halothane and sevoflurane, respectively, without alteration of NADPH-cytochrome c reductase activity. These anesthetics hastened the onset of the 445 nm absorption band formation which was shown by microsomes with carbon tetrachloride in the presence of NADPH under anaerobic conditions. These results indicate that the anesthetics isoflurane, enflurane, sevoflurane and halothane stimulate the reduction of cytochrome P450 results in the acceleration of the carbon tetrachloride dechlorination. These results may have implications for other type II drugs that are administered during anesthesia.
    DOI:
    10.1016/s0300-483x(96)03480-4
点击查看最新优质反应信息

文献信息

  • Chloropolyfluoro-derivatives of ethyl methyl ether
    作者:Paul L. Coe、Roger A. Rowbotham、John Colin Tatlow
    DOI:10.1016/s0022-1139(96)03549-x
    日期:1997.4
    Fluorination of 2-chloroethyl methyl ether by potassium tetrafluorocobaltate at 180–250 °C gave various tri-, tetra-, penta- and hexafluoro(2-chloroethyl methyl) ethers. Cobalt trifluoride afforded the same products in poorer recoveries. Structures were established spectroscopically. Cl2-UV and CHClFCHFOCHF2 gave halogeno-ethers by exchange of Cl for both H and also F.
    在180–250°C下用四氟钴酸钾氟化2-氯乙基甲基醚,得到各种三,四,五和六氟(2-氯乙基甲基)醚。三氟化钴可提供相同的产品,回收率较低。光谱确定结构。Cl 2 -UV和CHClFCHFOCHF 2通过将Cl交换为H和F生成卤代醚。
  • Deuterated 1,1-difluoro-2,2-dihaloethyl difluoromethyl ethers
    申请人:The Dow Chemical Company
    公开号:US04154971A1
    公开(公告)日:1979-05-15
    Deuterated halo ethers useful as anesthetics and having lower toxicity than undeuterated analogues further including compositions, and methods of use.
    氘代卤醚可用作麻醉剂,比未氘代的类似物毒性更低,还包括组合物和使用方法。
  • Schurig, Volker; Grosenick, Heiko; Green, Bernard S., Angewandte Chemie, 1993, vol. 105, # 11, p. 1690 - 1691
    作者:Schurig, Volker、Grosenick, Heiko、Green, Bernard S.
    DOI:——
    日期:——
  • 1,1,2-trifluoro-2-chloroethyl-difluoromethyl ether as an anesthetic agent
    申请人:AIRCO INC.
    公开号:US03469011A1
    公开(公告)日:1969-09-23
  • Hu Chang-Ming, Yu Zhang-Hua, Tu Ming-Hu, Youji huaxue (Org. Chem), 14 (1994) N 1, S 44-48
    作者:Hu Chang-Ming, Yu Zhang-Hua, Tu Ming-Hu
    DOI:——
    日期:——
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台